Dog Dementia: How to Recognize It and What Actually Helps

What we checked before telling you what to do

We reviewed peer-reviewed veterinary literature on canine cognitive dysfunction syndrome (CDS/CCD), the evidence base for approved and off-label treatments, clinical scoring tools used by veterinary neurologists, and independent assessments of supplement and dietary research. We applied the same standard we apply everywhere: we follow the strongest available evidence, not brand marketing or reassuring generalizations. Where the research is thin, we say so.

• ✓
  The DISHA symptom framework validated Peer-reviewed veterinary neurology research consistently uses the DISHA checklist (Disorientation, altered Interactions, Sleep-wake changes, House-soiling, Activity changes) as the most reliable behavioral screen for CCD — we confirmed it remains the clinical standard.
• ✓
  Selegiline's FDA approval and mechanism confirmed Selegiline (brand name Anipryl) is the only FDA-approved drug for CCD in dogs; its mechanism of increasing dopamine availability and reducing oxidative stress in the brain is well-established in veterinary pharmacology literature.
• ✓
  Dietary and supplement evidence reviewed critically Studies on antioxidant-enriched diets (specifically Hill's b/d, now reformulated) and medium-chain triglyceride supplementation show statistically significant cognitive improvements in controlled trials; evidence for SAMe and phosphatidylserine is promising but more limited.
• ✓
  Differential diagnoses that mimic CCD identified Hypothyroidism, hypertension, brain tumors, chronic pain, and vision or hearing loss all produce behavioral changes that closely resemble CCD — we confirmed that ruling these out first is not optional, it is the standard of care.
• ✓
  Environmental enrichment evidence assessed Controlled studies show that dogs given regular cognitive challenges (puzzle feeders, novel walks, scent work) show slower cognitive decline than unstimulated controls — the effect is real, not just intuitive.

There is no single silver bullet — here is how to layer the approaches that work

CCD is best managed with multiple strategies running simultaneously; the research suggests combining them produces better outcomes than any single intervention alone.

What people try first that wastes time — or makes things worse

Because CCD looks like vague "old age," owners often reach for intuitive fixes that the evidence simply does not support, or they delay action until the window for meaningful intervention has narrowed.

• ✗
  Waiting to "see if it gets better on its own" — CCD is a progressive neurodegenerative disease; it does not reverse or plateau without intervention, and the window when treatment has the most impact is early in the disease — waiting costs that window.
• ✗
  Assuming confusion is "just old age" without ruling out treatable causes — Hypothyroidism, hypertension, and chronic pain can all produce identical symptoms and are entirely treatable; skipping a vet workup means potentially missing a condition where your dog could fully recover.
• ✗
  Relying on unproven supplements sold specifically for "dog brain health" — The pet supplement market is unregulated and many products marketed for canine cognition have no peer-reviewed efficacy data; spending money on these instead of proven approaches (selegiline, MCT diet, omega-3s) is a poor trade.
• ✗
  Reducing activity to "let the old dog rest" — Reduced physical and mental stimulation actually accelerates cognitive decline in aging dogs; the evidence consistently shows that appropriate, regular enrichment is protective — rest is not the same as care.
• ✗
  Punishing house-soiling accidents — Dogs with CCD who soil indoors have lost cognitive access to the learned behavior of holding or signaling — they are not being defiant. Punishment adds distress without any rehabilitative effect and worsens anxiety, which independently accelerates cognitive symptoms.